These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9287388)

  • 1. Therapy with cyclosporine in psoriatic arthritis.
    Olivieri I; Salvarani C; Cantini F; Macchioni L; Padula A; Niccoli L; Boiardi L; Portioli I
    Semin Arthritis Rheum; 1997 Aug; 27(1):36-43. PubMed ID: 9287388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-modifying antirheumatic drug therapy for psoriatic arthritis.
    Salvarani C; Cantini F; Olivieri I
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.
    Spadaro A; Riccieri V; Sili-Scavalli A; Sensi F; Taccari E; Zoppini A
    Clin Exp Rheumatol; 1995; 13(5):589-93. PubMed ID: 8575136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
    Gül U; Gönül M; Kiliç A; Erdem R; Cakmak SK; Gündüz H
    Clin Ther; 2006 Feb; 28(2):251-4. PubMed ID: 16678646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary focus on cyclosporin A.
    Salvarani C; Boiardi L; Macchioni P; Pipitone N; Catanoso M; Pigatto P
    J Rheumatol Suppl; 2009 Aug; 83():52-5. PubMed ID: 19661542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.
    Fraser AD; van Kuijk AW; Westhovens R; Karim Z; Wakefield R; Gerards AH; Landewé R; Steinfeld SD; Emery P; Dijkmans BA; Veale DJ
    Ann Rheum Dis; 2005 Jun; 64(6):859-64. PubMed ID: 15528283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs.
    Marchesoni A; Lubrano E; Cauli A; Ricci M; Manara M
    J Rheumatol Suppl; 2015 Nov; 93():61-4. PubMed ID: 26523060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
    Karanikolas GN; Koukli EM; Katsalira A; Arida A; Petrou D; Komninou E; Fragiadaki K; Zacharioudaki A; Lasithiotakis I; Giavri E; Vaiopoulos G; Sfikakis PP
    J Rheumatol; 2011 Nov; 38(11):2466-74. PubMed ID: 21885499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of methotrexate in management of peripheral psoriatic arthritis - a systematic review.
    Ruhoff JT; Horn HC; Ellingsen T
    Dan Med J; 2019 Oct; 66(10):. PubMed ID: 31571573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugs.
    Spadaro A; Taccari E; Mohtadi B; Riccieri V; Sensi F; Zoppini A
    Clin Exp Rheumatol; 1997; 15(6):609-14. PubMed ID: 9444416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
    Gerards AH; Landewé RB; Prins AP; Bruyn GA; Goei Thé HS; Laan RF; Dijkmans BA
    Ann Rheum Dis; 2003 Apr; 62(4):291-6. PubMed ID: 12634224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic effects in patients with psoriatic arthritis treated with cyclosporine A.
    Boiardi L; Salvarani C; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Lodi L; Portioli I
    J Rheumatol; 1992 Dec; 19(12):1933-7. PubMed ID: 1284133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group.
    Stein CM; Pincus T; Yocum D; Tugwell P; Wells G; Gluck O; Kraag G; Torley H; Tesser J; McKendry R; Brooks RH
    Arthritis Rheum; 1997 Oct; 40(10):1843-51. PubMed ID: 9336420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.
    Sarzi-Puttini P; D'Ingianna E; Fumagalli M; Scarpellini M; Fiorini T; Chérié-Lignière EL; Panni B; Fiorentini F; Corbelli V; Beyene NB; Mastaglio C; Severi C; Locati M; Cazzola M; Menozzi G; Monti G; Saccardo F; Alfieri G; Atzeni F
    Rheumatol Int; 2005 Jan; 25(1):15-22. PubMed ID: 14530867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actual role of therapy with traditional disease-modifying antirheumatic drugs in psoriatic arthritis.
    Soriano ER
    J Rheumatol Suppl; 2012 Jul; 89():67-70. PubMed ID: 22751597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis.
    Salvarani C; Macchioni P; Olivieri I; Marchesoni A; Cutolo M; Ferraccioli G; Cantini F; Salaffi F; Padula A; Lovino C; Dovigo L; Bordin G; Davoli C; Pasero G; Alberighi OD
    J Rheumatol; 2001 Oct; 28(10):2274-82. PubMed ID: 11669169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis.
    Sarzi-Puttini P; Cazzola M; Panni B; Turiel M; Fiorini T; Belai-Beyene N; Chèrié-Lignièré EL
    Rheumatol Int; 2002 Apr; 21(6):234-8. PubMed ID: 12036210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse effects of cyclosporin a observed in rheumatoid arthritis and psoriatic arthritis].
    Prajs K; Fliciński J; Przepiera-Bedzak H; Brzosko I; Ostanek L
    Ann Acad Med Stetin; 2010; 56 Suppl 1():48-51. PubMed ID: 21365941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study.
    Drosos AA; Voulgari PV; Papadopoulos IA; Politi EN; Georgiou PE; Zikou AK
    Clin Exp Rheumatol; 1998; 16(6):695-701. PubMed ID: 9844762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose cyclosporine A in psoriatic arthritis: relation between soluble interleukin 2 receptors and response to therapy.
    Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Lodi L; Bisighini G; Portioli I
    J Rheumatol; 1992 Jan; 19(1):74-9. PubMed ID: 1556703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.